Effects of Different Doses of Irbesartan Combined With Spironolactone on Urinary Albumin Excretion Rate in Elderly Patients With Early Type 2 Diabetic Nephropathy-Reference-Cited by-同舟云学术

Effects of Different Doses of Irbesartan Combined With Spironolactone on Urinary Albumin Excretion Rate in Elderly Patients With Early Type 2 Diabetic Nephropathy

Published:2018-05 Issue:5 Volume:355 Page:418-424
ISSN:0002-9629
Container-title:The American Journal of the Medical Sciences
language:en
Short-container-title:The American Journal of the Medical Sciences

Author:

Chen Yingying,Liu Peng,Chen Xia,Li Yanan,Zhang Fengmei,Wang Yangang

Funder

Shandong Province Medical and Health Technology Development Program

Publisher

Elsevier BV

Subject

General Medicine

Reference23 articles.

1. Guidelines for prevention and treatment of type 2 diabetes in China;Chin J Diabetes Mellitus (Article in Chinese),2014

2. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes;Parving;N Engl J Med,2001

3. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate;Schjoedt;Diabetologia,2004

4. Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial;Kato;Clin Exp Nephrol,2015

5. Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy;Mehdi;J Am Soc Nephrol,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of xenogeneic transplantation of umbilical cord-derived mesenchymal stem cells combined with irbesartan on renal podocyte damage in diabetic rats;Stem Cell Research & Therapy;2024-07-30

2. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

3. Renoprotective Effects of Mineralocorticoid Receptor Antagonists Against Diabetic Kidney Disease;Advanced Biology;2023-12-08

4. Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis;American Journal of Nephrology;2023-10-04

5. A Narrative Review of Signaling Pathway and Treatment Options for Diabetic Nephropathy;Current Molecular Medicine;2023-07-27